Syndax Pharmaceuticals Inc
SEC Filing List
SNDX CIK: 0001395937
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G | 04/30/2026 | ||||
| DEF 14A | Definitive proxy statements | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| ARS | Annual report to security holders | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| 8-K | Current report filing | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| SCHEDULE 13G/A | 03/27/2026 | ||||
| 8-K | Current report filing | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/26/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Syndax Pharmaceuticals Inc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/26/2026 | |
| No record found. | |||||
| Load More | |||||
